(1) Cooksley TJ,
Haji-Michael P.
Post-operative critical care management of patients undergoing cytoreductive surgery and Heated Intraperitoneal Chemotherapy (HIPEC).
World J Surg Oncol.
2011;9:169.
(2) Vaira M,
Cioppa T,
D'Amico S et al.
Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction,
peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC).
Experience of ten years.
In Vivo.
2010;24:79-84.
(3) Gill RS,
Al Adra DP,
Nagendran J et al.
Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival,
mortality,
and morbidity.
J Surg Oncol.
2011;104:692-698.
(4) Brent Goslin,
Shruti Sevak,
Arida Siripong et al.
Outcomes of cytoreduction with hyperthermic intraperitoneal chemotherapy: our experience at a Midwest community hospital.
The American Journal Of Surgey.
In press.
(5) Raue W,
Tsilimparis N,
Langelotz C et al.
Initial results after implementation of a multimodal treatment for peritoneal malignancies.
Acta Chir Belg.
2011;111:68-72.
(6) Rueth NM,
Murray SE,
Huddleston SJ et al.
Severe electrolyte disturbances after hyperthermic intraperitoneal chemotherapy: oxaliplatin versus mitomycin C.
Ann Surg Oncol.
2011;18:174-180.
(7) Wooten L.
Appendix B: nursing care of the HIPEC patient.
Curr Probl Cancer.
2009;33:227-237.
(8) Schmidt C,
Creutzenberg M,
Piso P,
Hobbhahn J,
Bucher M.
Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Anaesthesia.
2008;63:389-395.
(9) Lopez-Berlanga JL,
De Miguel A,
Elvira A.
[Anesthesia and postoperative care of 11 patients undergoing peritonectomy and hypothermic intraperitoneal chemotherapy].
Rev Esp Anestesiol Reanim.
2004;51:423-428.
(10) Gonzalez-Moreno S,
Gonzalez-Bayon LA,
Ortega-Perez G.
Hyperthermic intraperitoneal chemotherapy: Rationale and technique.
World J Gastrointest Oncol.
2010;2:68-75.
(11) Yan TD,
Haveric N,
Carmignani CP,
Sugarbaker PH.
Computed tomographic characterization
of malignant peritoneal mesothelioma.
Tumori.
2005;91:394-400.
(12) Yan TD,
Haveric N,
Carmignani CP,
Sugarbaker PH.
Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy.
Cancer.
2005;103:839-49.
(13) de Bree E,
Koops W,
Kroger R,
et al.
Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Eur J Surg Oncol.
2006;32:65-71.
(14) Jacquet P,
Jelinek JS,
Chang D,
et al.
Abdominal computed tomographic scan in the selection
of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery.
J Am Coll Surg.
1995;181:530-8.
(15) Jacquet P,
Jelinek JS,
Steves MA,
et al.
Evaluation of computed tomography in patients with peritoneal carcinomatosis.
Cancer.
1993;72:1631-6.
(16) Low R,
Saleh F,
Song S,
et al.
Treated ovarian cancer: Comparison of MR imaging with serum CA-125 level and physical examination: A longitudinal study.
Radiology.
1999;211:519-28.